Antidepressant-like effect of riparin II from Aniba riparia in mice: Evidence for the involvement of the monoaminergic system

Fundamental and Clinical Pharmacology

Volumn 27, Issue 2, 2013, Pages 129-137

  Teixeira, Caroline Porto Leite ^a   De Melo, Carla Thiciane Vasconcelos ^a   De Araújo, Fernando Luiz Oliveira ^a   De Carvalho, Allyne Mara Rodrigues ^a   Silva, Maria Izabel Gomes ^a   Barbosa Filho, José Maria ^b   Macêdo, Danielle Silveira ^a   De Barros Viana, Glauce Socorro ^a   De Sousa, Francisca Cléa Florenço ^a  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^b FEDERAL UNIVERSITY OF PARAÍBA   (Brazil)

Author keywords

Aniba riparia; Antidepressant like effect; Dopaminergic system; Noradrenergic system; Riparin II; Serotonergic system

Indexed keywords

1 (2 METHOXYPHENYL) 4 (4 PHTHALIMIDOBUTYL)PIPERAZINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ANTIDEPRESSANT AGENT; FENCLONINE; HERBACEOUS AGENT; PRAZOSIN; RIPARIN II; SULPIRIDE; UNCLASSIFIED DRUG;

ANIBA RIPARIA; ANIMAL EXPERIMENT; ANTIDEPRESSANT ACTIVITY; ARTICLE; DEPRESSION; DOPAMINERGIC SYSTEM; FORCED SWIMMING TEST; FRUIT; MALE; MEDICINAL PLANT; MONOAMINERGIC SYSTEM; MOUSE; NONHUMAN; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM; TAIL SUSPENSION TEST;

ADRENERGIC NEURONS; ANIMALS; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ANIMAL; BENZAMIDES; DOPAMINE AGENTS; FRUIT; HINDLIMB SUSPENSION; IMMOBILITY RESPONSE, TONIC; LAURACEAE; MALE; MICE; MOTOR ACTIVITY; SEROTONIN AGENTS; SWIMMING; TYRAMINE;

EID: 84874385599     PISSN: 07673981     EISSN: 14728206     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2011.00973.x     Document Type: Article

References (43)

1. Wong M.L., Licinio J. Research and treatment approaches to depression. Nat. Rev. Neurosci. (2001) 2 343-351.
2. Nestler E.J., Barrot M., DiLeone R.J., Eisch A.J., Gold S.J., Monteggia L.M. Neurobiology of depression. Neuron (2002) 34 13-25.
3. Berton O., Nestler E.J. Newapproaches to antidepressant drug discovery: beyond monoamines. Nat. Rev. Neurosci. (2006) 7 137-151.
4. Tran P.V., Bymaster F.P., McNamara R.K., Potter W.Z. Dual monoamine modulation for improved treatment of major depressive disorder. J. Clin. Psychopharmacol. (2003) 23 78-86.
5. Bhattacharya S.K., Bhattacharya A., Sairam K., Ghosal S. Anxiolytic-antidepressant activity of Withania somnifera glycowithanolides: an experimental study. Phytomedicine (2000) 7 463-469.
6. Kasper S., Anghelescu I.G., Szegedi A., Dienel A., Kieser M. Superior efficacy of St. John's wort extract WS 5570 compared to placebo in patients with major depression: a randomized, double-blind, placebo-controlled, multi-center trial. BMC Med. (2006) 23 4-14.
7. Barbosa-Filho J.M., Yoshida M., Gottlieb O.R., Barbosa R.C.S.B.C., Giesbrecht A.M., Young C.M. Benzoyl esters and amides, styrylpyrones and neolignans from the fruits of Aniba riparia. Phytochemistry (1987) 26 2615-2617.
8. Sousa F.C.F., Melo C.T.V., Monteiro A.P. et al. Antianxiety and antidepressant effects of riparin III from Aniba riparia (NEES) MEZ (Lauraceae) in mice. Pharmacol. Biochem. Behav. (2004) 78 27-33.
9. Sousa F.C.F., Leite C.P., Melo C.T.V. et al. Evaluation of effects of N-(2-hydroxybenzoyl) tyramine (riparin II) from Aniba riparia (NEES) MEZ (Lauraceae) in anxiety models in mice. Biol. Pharm. Bull. (2007) 30 1212-1216.
10. Barauna S.C., Kaster M.P., Heckert B.T. et al. Antidepressant-like effect of lectin from Canavalia brasiliensis (ConBr) administered centrally in mice. Pharmacol. Biochem. Behav. (2006) 85 160-169.
11. Machado D.G., Kaster M.P., Binfare R.W. et al. Antidepressant-like effect of the extract from leaves of Schinus molle L. inmice: evidence for the involvement of themonoaminergic system. Prog. Neuropsychopharmacol. Biol. Psychiatry (2007) 31 421-428.
12. Kaster M.P., Raupp I., Binfare R.W., Andreatini R., Rodrigues A.L.S. Antidepressant- like effect of lamotrigine in the mouse forced swimming test: evidence for the involvement of the noradrenergic system. Eur. J. Pharmacol. (2007) 565 119-124.
13. D'Aquila P.S., Collu M., Gessa G.L., Serra G. The role of dopamine in the mechanism of action of antidepressant drugs. Eur. J. Pharmacol. (2000) 405 365-373.
14. Anguelova M., Benkelfat C., Turecki G.A systematic review of association studies investigating genes coding for serotonin receptors and the serotonin transporter: I. Affective disorders. Mol. Psychiatry (2003) 8 574-591.
15. Anguelova M., Benkelfat C., Turecki G.A systematic review of association studies investigating genes coding for serotonin receptors and the serotonin transporter: II. Suicidal behavior. Mol. Psychiatry (2003) 8 646-653.
16. Drevets W.C. Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders. Curr. Opin. Neurobiol. (2001) 11 240-249.
17. Schreiber R., Brocco M., Audinot V., Gobert A., Veiga S., Millan M.J.(1-(2, 5-dimethoxy-4- iodophenyl)-2-aminopropane)-induced head twitches in the rat are mediated by 5- hydroxytryptamine 5-HT2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists. J. Pharmacol. Exp. Ther. (1995) 273 101-112.
18. Cryan J.F., Markou A., Lucki I. Assessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol. Sci. (2002) 23 238-245.
19. Kaster M.P., Santos A.R.S., Rodrigues A.L.S. Involvement of 5-HT1A receptors in the antidepressant-like effect of adenosine in the mouse forced swimming test. Brain Res. Bull. (2005) 67 53-61.
20. Rodrigues A.L.S., Silva G.L., Matteussi A.S. et al. Involvement of monoaminergic system in the antidepressant-like effect of the hydroalcoholic extract of Siphocampylus verticillatus. Life Sci. (2002) 70 1347-1358.
21. Asakura W., Matsumoto K., Ohta H., Watanabe H. Involvement of dopamine D2 receptor mechanism in the REM sleep deprivation-induced increase in swimming activity in the forced swimming test. Pharmacol. Biochem. Behav. (1994) 48 43-46.
22. Bourin M., Hascoet M., Colombel M.C., Redrobe J.P., Baker G.B. Differential effects of clonidine, lithium and quinine in the forced swimming test in mice for antidepressants: possible roles of serotoninergic systems. Eur. Neuropsychopharmacol. (1996) 6 231-236.
23. Zomkowski A.D., Hammes L., Lin J., Calixto J.B., Santos A.R.S., Rodrigues A.L.S. Agmatine produces antidepressant-like effects in two models of depression in mice. Neuroreport (2002) 13 387-391.
24. Mantovani M., Kaster M.P., Pértile R., Calixto J.B., Rodrigues A.L.S., Santos A.R.S. Mechanisms involved in the antinociception caused by melatonin in mice. J. Pineal Res. (2006) 41 382-389.
25. Steru L., Chermat R., Thierry B., Simon P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology (1985) 85 367-370.
26. Cunha M.P., Machado D.G., Bettio L.E.B., Capra J.C., Rodrigues A.L.S. Interaction of zinc with antidepressants in the tail suspension test. Prog. Neuropsychopharmacol. Biol. Psychiatry (2008) 32 1913-1920.
27. Cryan J.F., Mombereau C., Vassout A. The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice. Neurosci. Biobehav. Rev. (2005) 29 571-625.
28. Porsolt R.D., Bertin A., Jalfre M. Behavioral despair in mice: a primary screening test for antidepressants. Arch. Int. Pharmacodyn. Ther. (1977) 229 327-336.
29. Petit-Demouliere B., Chenu F., Bourin M. Forced swimming test in mice: a review of antidepressant activity. Psychopharmacology (Berl.) (2005) 177 245-255.
30. Urani A., Chourbaji S., Gass P. Mutant mouse models of depression: candidate genes and current mouse lines. Neurosci. Biobehav. Rev. (2005) 29 805-828.
31. Elhwuegi A.S. Central monoamines and their role in major depression. Prog. Neuropsychopharmacol. Biol. Psychiatry (2004) 28 435-451.
32. Millan M.J. The role of monoamines in the actions of established and "novel" antidepressant agents: a critical review. Eur. J. Pharmacol. (2004) 500 371-384.
33. Dailly E., Chenu F., Renard C.E., Bourin M. Dopamine, depression and antidepressants. Fundam. Clin. Pharmacol. (2004) 18 601-607.
34. Papakostas G.I. Dopaminergic-based pharmacotherapies for depression. Eur. Neuropsychopharmacol. (2006) 16 391-402.
35. Yamada J., Sugimoto Y., Yamada S. Involvement of dopamine receptors in the anti-immobility effects of dopamine re-uptake inhibitors in the forced swimming test. Eur. J. Pharmacol. (2004) 504 207-211.
36. Taylor L. The healing power of rainforest herbs. A guide to understanding and using herbal medicinals, New York, Square One Publishers, 2005.
37. Kitada Y., Miyauchi T., Kanazawa Y., Nakamichi H., Satoh S. Involvement of alpha- and beta 1-adrenergic mechanisms in the immobility-reducing action of desipramine in the forced swimming test. Neuropharmacology (1983) 22 1055-1060.
38. Danysz W., Kostowski W., Kozak W., Hauptmann M. On the role of noradrenergic neurotransmission in the action of desipramine and amitriptyline in animal models of depression. Pol. J. Pharmacol. Pharm. (1986) 38 285-298.
39. Masuda Y., Ohnuma S., Sugiyama T.α2-adrenoceptor activity induces the antidepressant-like glycolipid in mouse forced swimming. Methods Find. Exp. Clin. Pharmacol. (2001) 23 19-21.
40. Redrobe J.P., Bourin M., Colombel M.C., Baker G.B. Dose-dependent noradrenergic and serotonergic properties of venlafaxine in animal models indicative of antidepressant activity. Psychopharmacology (Berl.) (1998) 138 1-8.
41. Page M.E., Detke M.J., Dalvi A., Kirby L.G., Lucki I. Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test. Psychopharmacology (Berl.) (1999) 147 162-167.
42. O'Leary O.F., Bechtholt A.J., Crowley J.J., Hill T.E., Page M.E., Lucki I. Depletion of serotonin and catecholamines block the acute behavioral response to different classes of antidepressant drugs in the mouse tail suspension test. Psychopharmacology (Berl.) (2007) 192 357-371.
43. Bymaster F.P., Zhang W., Carter P.A. et al. Fluoxetine, but not other selective serotonin uptake inhibitors, increases norepinephrine and dopamine extracellular levels in prefrontal cortex. Psychopharmacology (Berl.) (2002) 160 353-361.